OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 124 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $144,000 | -26.2% | 335,200 | -3.0% | 0.00% | – |
| Q1 2016 | $195,000 | -69.1% | 345,700 | -5.7% | 0.00% | -100.0% |
| Q4 2015 | $631,000 | -18.5% | 366,600 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $774,000 | -57.4% | 366,600 | 0.0% | 0.00% | -66.7% |
| Q2 2015 | $1,815,000 | -29.2% | 366,600 | -18.9% | 0.00% | -25.0% |
| Q1 2015 | $2,564,000 | 0.0% | 452,188 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $2,564,000 | +33.1% | 452,188 | 0.0% | 0.00% | +33.3% |
| Q3 2014 | $1,926,000 | -26.3% | 452,188 | +6.9% | 0.00% | -25.0% |
| Q2 2014 | $2,615,000 | +10.0% | 423,161 | +1.8% | 0.00% | +33.3% |
| Q1 2014 | $2,377,000 | +13.6% | 415,647 | +13.4% | 0.00% | 0.0% |
| Q4 2013 | $2,093,000 | -8.0% | 366,600 | -1.1% | 0.00% | -25.0% |
| Q3 2013 | $2,276,000 | +16.7% | 370,665 | +11.2% | 0.00% | 0.0% |
| Q2 2013 | $1,951,000 | – | 333,465 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 5,427,559 | $2,334,000 | 1.60% |
| Scale Management, LLC | 1,312,575 | $564,000 | 1.34% |
| Foresite Capital Management III, LLC | 2,542,575 | $1,093,000 | 0.75% |
| BVF INC/IL | 5,252,100 | $2,258,000 | 0.48% |
| TIVERTON ASSET MANAGEMENT LLC | 45,313 | $4,261,000 | 0.18% |
| Baupost Group | 22,268,399 | $9,575,000 | 0.13% |
| Rhenman & Partners Asset Management AB | 1,200,000 | $516,000 | 0.09% |
| NEA Management Company, LLC | 370,900 | $1,595,000 | 0.08% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $2,649,000 | 0.06% |
| Palo Alto Investors LP | 1,673,024 | $719,000 | 0.05% |